Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04439968
Other study ID # 56759
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date August 10, 2021
Est. completion date December 31, 2025

Study information

Verified date April 2024
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Implementing target ranges for regional cerebral saturations in extremely preterm infants in the first week of life may improve neurodevelopmental outcomes at 22-26 months corrected age compared to those without targeted cerebral saturations (Csat) using near-infrared spectroscopy (NIRS). Infants will be randomized to a targeted cerebral saturation monitoring group with visible reading of Csat or to a control group with cerebral saturation monitoring, but with blinded Csat measures. Those in the targeted Csat group will follow a treatment guideline to maintain cerebral oxygenation in the target range. The primary outcome is neurodevelopmental outcome as determined by Bayley III cognitive scale score.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group N/A to 2 Days
Eligibility Inclusion Criteria: - Very preterm infants with gestational age at least 23 weeks but less than 29 completed weeks - Less than 6 hours of age Exclusion Criteria: - Skin integrity insufficient to allow placement of NIRS sensors - Decision not to provide full intensive care support - Congenital condition, other than premature birth, that adversely affects life expectancy or neurodevelopment

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Clinical algorithm
In order to maintain cerebral saturations within targeted range, subjects in the targeted Csat arm will undergo clinical interventions based on clinical algorithm. Interventions may include administration of inotropes, fluid resuscitation, transfusion of blood products, and/or adjustment to respiratory support.

Locations

Country Name City State
United States Lucile Packard Children's Hospital Stanford Palo Alto California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Burden of Cerebral hypoxia or hyperoxia Burden of cerebral hypoxia or hyperoxia from NIRS measures From birth until first 7 days of life
Primary Neurodevelopmental outcome Neurodevelopmental outcomes will be assessed using the cognitive component of the Bayley Scales of Infant Development-III at 22-26 months of age. Scores range from 55-145 with higher number representing a better neurodevelopmental outcome. 22-26 months of age
Secondary Death Death prior to hospital discharge from birth until hospital discharge, an average of 3 months.
Secondary Retinopathy of prematurity Occurrence of retinopathy of prematurity prior to hospital discharge from birth until hospital discharge, an average of 3 months.
See also
  Status Clinical Trial Phase
Recruiting NCT05028023 - Tracheal Dilatation in Pediatric Patients With Acquired Tracheal Stenosis, and the Effects of Apneic Oxygenation N/A
Recruiting NCT05048680 - Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly N/A
Completed NCT03303118 - The Effects of Hypobaria vs Hypoxia on Cerebral Functions. N/A
Recruiting NCT02133638 - Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery Phase 4
Recruiting NCT06320743 - Cerebral and Peripheral Near Infrared Spectroscopy Monitoring in Low and High Flow Anaesthesia in Pediatric N/A
Recruiting NCT04971564 - Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia
Completed NCT01620203 - Observational Study in Preterm Infants With Intracranial Hemorrhage
Completed NCT03916133 - Analysis of Selective Cerebrovascular Distribution With FDCT in the Angiosuite N/A
Completed NCT01432184 - Feasibility Trial to Maintain Normal Cerebral Oxygen Saturation in High-Risk Cardiac Surgery N/A
Completed NCT05652426 - The Effect of Hypoxic and Normoxic Cerebral Oximetry Levels on Cognitive Functions After Carotid Endarterectomy
Completed NCT02605005 - The Impact of a Beach Chair Position During Shoulder Arthroscopy on Regional Cerebral Oxygen Saturation : Comparison of Interscalene Block and General Anesthesia N/A
Completed NCT01757561 - The Difference in Cerebral Oxygenation Between Propofol and Sevoflurane N/A
Active, not recruiting NCT05171881 - Brain Oxygenation-II Phase 2
Not yet recruiting NCT06316596 - Brain Oxygenation in Newborns Due to Neuroaksial Methods N/A
Completed NCT06306950 - Prioritization of Cerebral Deoxygenation in Severe Traumatic Brain Injury and Mortality Benefit. N/A